Vertex, Inc. Class A VERX 深 沪
等待开盘 02-04 09:30:00 美东时间
15.87
-2.830
-15.13%
华盛通- 最 高18.51
- 今 开18.32
- 成交量 545.87万股
- 最 低 15.69
- 昨 收 18.70
- 总市值 25.39亿
- 52周最高 48.00
- 市盈率 静 --
- 换手率 3.41%
- 52周最低 15.69
- 委 比 -9.93%
- 总股本 1.60亿
- 历史最高 60.71
- 量 比 2.73
- 振 幅 15.08%
- 历史最低 9.44
- 每 手 1
- 风险率 9.25%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅213.87%！Wave Life Sciences获Canaccord Genuity升目标价至43美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences Ltd."买入"评级，目标价从40美元升至43美元；花旗：维持Palantir Technologies"买入"评级，目标价从235美元升至260美元
今天 12:15
This Vertex Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a comple...
02-03 22:03
Piper Sandler Downgrades Vertex to Neutral, Lowers Price Target to $20
Piper Sandler analyst Hannah Rudoff downgrades Vertex (NASDAQ:VERX) from Overweight to Neutral and lowers the price target from $32 to $20.
02-03 19:57
Built In Honors Vertex in Its Esteemed 2026 Best Places To Work Awards
Vertex, Inc. has been recognized as one of Built In’s Best Places to Work in 2026, marking three consecutive years of honor. The company was placed on two Best Remote Places to Work lists, highlighting its commitment to benefits, compensation, and inclusive culture. Vertex offers flexible work options, professional growth opportunities, and a purpose-driven environment, supporting global commerce. The recognition underscores Vertex’s dedication t...
01-06 14:00
Vertex Minerals Director Increases Shareholding via On‑Market Purchase
An update from Vertex Minerals Ltd. ( ($AU:VTX) ) is now available. Vertex Mine...
01-05 14:17
专利悬崖下，2026 药企并购潮将至
（来源：抗体圈） 专利压力成核心推手 “2026 到 2027 年，我们将迎来一轮大规模并购季。”Coya Therapeutics CEO 阿伦・斯瓦米...
2025-12-17 14:51
【海外瞭望】谷歌发布新一代图像生成模型Nano Banana Pro，2030年全球电视和视频市场或将达万亿美元
综合整理|李雪凝 人工智能 谷歌 Veo 3.1 视频生成模型，提供视频编辑功能 近日，谷歌Veo3.1 版本支持在视频中添加对象，并自动将其融入原有...
2025-12-09 11:13
Reported Saturday, Vertex Announces Pivotal CASGEVY Studies In Children Ages 5-11 Years Showing Transformative Potential And Consistent Efficacy And Safety Versus Ages 12 Years And Older
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients --
2025-12-08 17:35
V2X secures $252.05M U.S. Air Force contract
V2X (VVX) was awarded a $252,050,925 cost-plus fixed-fee indefinite contract action for base support services in support of the Iraq F-16 program. This contract provides for base operating support, ba...
2025-11-22 06:14
Vertex Amends Credit Agreement with PNC Bank
Vertex ( ($VERX) ) has shared an update. On November 14, 2025, Vertex, Inc. ent...
2025-11-21 05:44
